SEC Comment Letter 0000000000-26-005109 to PALISADE BIO, INC. (PALI)
PALISADE BIO, INC.
Date: May 19, 2026 · CIK: 0001357459 · Accession: 0000000000-26-005109
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-295815
Letter
May 19, 2026 J.D. Finley Chief Executive Officer Palisade Bio, Inc. 4600 South Syracuse Street, Suite 900 Denver, Colorado 80237 Re: Palisade Bio, Inc. Registration Statement on Form S-3 Filed May 12, 2026 File No. 333-295815 Dear J.D. Finley: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at 202-551-6761 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Jeffrey C. Thacker
Show Raw Text
May 19, 2026 J.D. Finley Chief Executive Officer Palisade Bio, Inc. 4600 South Syracuse Street, Suite 900 Denver, Colorado 80237 Re: Palisade Bio, Inc. Registration Statement on Form S-3 Filed May 12, 2026 File No. 333-295815 Dear J.D. Finley: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at 202-551-6761 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Jeffrey C. Thacker